Psychiatry Investig > Volume 19(9); 2022 > Article |
|
Availability of Data and Material
The datasets generated or analyzed during the study are available from the corresponding author on reasonable request.
Conflicts of Interest
The authors have no potential conflicts of interest to disclose.
Author Contributions
Conceptualization: all authors. Data curation: all authors. Formal analysis: all authors. Funding acquisition: all authors. Investigation: all authors. Methodology: all authors. Project administration: all authors. Resources: all authors. Software: all authors. Supervision: all authors. Validation: all authors. Visualization: all authors. Writing—original draft: all authors. Writing—review & editing: all authors.
Funding Statement
None
Items | Controls (N=28) | Pre-operative group (N=25) | p-value |
---|---|---|---|
Age (yr) | 3.5±0.9 | 3.5±0.6 | 0.802 |
Sex | 0.092 | ||
Male | 26 (92.8) | 19 (76.0) | |
Female | 2 (7.2) | 6 (24.0) |
Item | Controls (N=28) | Pre-operative group (N=25) | p-value |
---|---|---|---|
Emotionally reactive | 0.045* | ||
Normal | 21 (75.0) | 14 (56.0) | |
Borderline | 7 (25.0) | 6 (24.0) | |
Clinical | 0 (0) | 5 (20.0) | |
Anxious | <0.001* | ||
Normal | 25 (89.3) | 11 (44.0) | |
Borderline | 3 (10.7) | 7 (28.0) | |
Clinical | 0 (0) | 7 (28.0) | |
Somatic complaints | <0.001* | ||
Normal | 28 (100) | 14 (56.0) | |
Borderline | 0 (0) | 8 (32.0) | |
Clinical | 0 (0) | 3 (12.0) | |
Withdrawn | <0.001* | ||
Normal | 21 (75.0) | 12 (48.0) | |
Borderline | 7 (25.0) | 2 (8.0) | |
Clinical | 0 (0) | 11 (44.0) | |
Sleep problem | 0.098 | ||
Normal | 28 (100) | 22 (88.0) | |
Borderline | 0 (0) | 1 (4.0) | |
Clinical | 0 (0) | 2 (8.0) | |
Attention problem | 0.131 | ||
Normal | 15 (53.6) | 19 (76.0) | |
Borderline | 3 (10.7) | 3 (12.0) | |
Clinical | 10 (35.7) | 3 (12.0) | |
Aggressive behavior | 0.034* | ||
Normal | 24 (85.7) | 15 (60.0) | |
Borderline | 0 (0) | 3 (12.0) | |
Clinical | 4 (14.3) | 7 (28.0) | |
Internal | <0.001* | ||
Normal | 19 (67.9) | 5 (20.0) | |
Borderline | 6 (21.4) | 2 (8.0) | |
Clinical | 3 (10.7) | 18 (72.0) | |
External | 0.003* | ||
Normal | 24 (85.7) | 11 (44.0) | |
Borderline | 0 (0) | 2 (8.0) | |
Clinical | 4 (14.3) | 12 (48.0) |
Item | Control (N=28) | Pre-operative group (N=25) | p-value |
---|---|---|---|
Affective problems | <0.001* | ||
Normal | 28 (100) | 11 (44.0) | |
Borderline | 0 (0) | 3 (12.0) | |
Clinical | 0 (0) | 11 (44.0) | |
Anxiety problems | <0.001* | ||
Normal | 28 (100) | 16 (64.0) | |
Borderline | 0 (0) | 1 (4.0) | |
Clinical | 0 (0) | 8 (32.0) | |
Pervasive developmental problems | <0.001* | ||
Normal | 28 (100) | 4 (16.0) | |
Borderline | 0 (0) | 4 (16.0) | |
Clinical | 0 (0) | 17 (68.0) | |
Attention-deficit/hyperactivity problems | 0.003* | ||
Normal | 28 (100) | 18 (72.0) | |
Borderline | 0 (0) | 5 (20.0) | |
Clinical | 0 (0) | 2 (8.0) | |
Oppositional defiant problems | 0.003* | ||
Normal | 28 (100) | 18 (72.0) | |
Borderline | 0 (0) | 2 (8.0) | |
Clinical | 0 (0) | 5 (20.0) |